Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Thrombin-binding anticoagulant disclosed by Japanese scientists

Jan. 10, 1997

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Jan. 9, 1997

Potential HIV-1 therapy disclosed by Houghten

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

Galderma develops novel compounds active on cell differentiation and proliferation

Jan. 9, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...